Role of docetaxel in the treatment of gastric cancer
Cascinu, S.
Tumori 87(6): A10-A12
2001
ISSN/ISBN: 0300-8916 PMID: 11995696 Document Number: 526256
Document emailed within 1 workday
Related Documents
Wada, T.; Kunisaki, C.; Hasegawa, S.; Kaida, S.; Tamura, S.; Ono, H.; Oshima, T.; Fujii, S.; Kosaka, T.; Makino, H.; Akiyama, H.; Endo, I. 2013: A case of locally advanced gastric cancer in which the patient underwent curative gastrectomy after treatment with systemic chemotherapy with bi-weekly s-1/docetaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(11): 1533-1536Armand, J.P. 2000: Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27 Suppl. 2: 223-230
Zhang, Y.-F.; Yu, Y.-F.; Lu, S. 2009: Comparison of single-agent docetaxel versus docetaxel plus platinum combination agent in second-line treatment for advanced non-small cell lung cancer Zhonghua Yi Xue Za Zhi 89(22): 1544-1548
Yoshida, M.; Ohtsu, A. 2001: New drugs for unresectable or recurrent gastric cancer--paclitaxel and docetaxel Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 4): 404-408
Kunisaki, C.; Takahashi, M.; Nagahori, Y.; Makino, H.; Takagawa, R.; Sato, T.; Oshima, T.; Fujii, S.; Kosaka, T.; Ono, H.A.; Akiyama, H.; Shimada, H. 2008: Phase i study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer Anticancer Research 28(4c): 2473-2478
Sato, T.; Oshima, T.; Yamamoto, N.; Fukahori, M.; Makino, H.; Nagano, Y.; Fujii, S.; Rino, Y.; Masuda, M.; Imada, T.; Kunisaki, C. 2009: A case of advanced gastric cancer successfully treated by combination therapy of S-1 and docetaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1541-1544
Polyzos, A.; Tsavaris, N.; Kosmas, C.; Polyzos, K.; Giannopoulos, A.; Felekouras, E.; Nikiteas, N.; Kouraklis, G.; Griniatsos, J.; Safioleas, M.; Stamatakos, M.; Pikoulis, E.; Papachristodoulou, A.; Gogas, H. 2006: Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin Anticancer Research 26(5b): 3749-3753
Takizawa, M.; Hirano, M.; Murakami, N.; Uno, Y.; Kikuchi, T.; Nozawa, H.; Hara, T.; Asaumi, Y.; Kikkawa, H. 2002: A case of recurrent gastric cancer that responded dramatically to docetaxel and 5'-DFUR combination chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(9): 1647-1650
Numata, M.; Oshima, T.; Amano, S.; Fukahori, M.; Godai, T.; Sato, T.; Makino, H.; Fujii, S.; Rino, Y.; Masuda, M.; Imada, T.; Kunisaki, C. 2011: Three cases of advanced gastric cancer successfully treated by combination therapy of biweekly S-1 and docetaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(3): 443-448
Iwakura, S.; Shimamoto, T.; Higashiguchi, T.; Nakase, T.; Shimada, K.; Kunimoto, H.; Aoki, Y. 2012: A case of gastric cancer with peritoneal dissemination and massive ascites successfully treated with S-1/docetaxel therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(8): 1251-1253
Wang, Z.-H.; Guo, J.; Chen, Z.; Li, C.-Z.; Sheng, L.-J.; Zhou, D.-G.; Liu, B.; Liu, J.; Wang, Q.-C.; Zhang, E.-N. 2008: Preliminary study of biweekly regimen of docetaxel, oxaliplatin, 5-fluorouracil and leucovorin for advanced gastric cancer Zhonghua Zhong Liu Za Zhi 30(5): 389-391
Meng, H.; Lu, C.-d.; Dai, D.-j.; Sun, Y.-l.; Tanigawa, N. 2004: Elevated expression level of wild-type survivin in gastric cancer promotes in vitro docetaxel-resistance Zhonghua Yi Xue Za Zhi 84(24): 2060-2063
Matsuya, H.; Kawasaki, H.; Shibata, S.; Miyamoto, K.; Sasaki, M.; Itoh, J.; Kijima, H. 2007: A case of gastric cancer with severe lymph node metastasis effectively treated with docetaxel / S-1 as neoadjuvant chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(10): 1643-1646
Nagase, T.; Kanai, T.; Nakagawa, M.; Kumamoto, Y.; Imai, S.; Wada, O.; Honda, T.; Hoshino, G.; Atsukawa, K.; Sakaguchi, T.; Shiba, T.; Nonaka, T.; Imajyo, K.; Ogawa, Y. 2010: Analysis of four patients with advanced gastric cancer undergoing gastrectomy after pre-operative combination chemotherapy using docetaxel, cisplatin and S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(11): 2177-2179
Yamasaki, A.; Shoda, M.; Iijima, H.; Nagai, S.; Wada, J.; Suzuki, H.; Chikazawa, N.; Tasaka, T.; Kameda, C.; Tanaka, H.; Ikebe, M.; Jo, E.; Sato, N.; Nakamura, M.; Sekine, F.; Morisaki, T.; Katano, M. 2009: A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model Anticancer Research 29(3): 843-850
Ishikawa, T.; Oyamada, H.; Suzuki, K.; Matsuyama, R.; Isozaki, Y.; Okita, M.; Nagao, Y.; Kiyota, K.; Kokura, S.; Yoshikawa, T. 2008: A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis responding remarkably to combination chemotherapy of docetaxel, CDDP and S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(13): 2397-2400
Nemoto, H.; Sato, T.; Rino, Y.; Uchiyama, M.; Atsumi, Y.; Hasegawa, S.; Tamagawa, H.; Oshima, T.; Yukawa, N.; Yoshikawa, T.; Imada, T.; Masuda, M. 2013: Curative resection of a case of advanced gastric cancer with peritoneal dissemination responding well to combination chemotherapy of docetaxel,cisplatin and S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(9): 1221-1224
Rahman, F.; Rahardjo, H.Erlianti.; Ariwicaksono, S.Cahyo.; Hafizar, H.; Sembiring, M.Gozali.Arif.; Andika, R.; Patandung, R.; Hidianingsih, S.; Hotasi, S.L. 2017: The Role of Docetaxel in Non-Castrate Resistant Metastatic Prostate Cancer: An Evidence-based Case Report Acta Medica Indonesiana 49(1): 74-78
Burris, H.A. 2000: Docetaxel (Taxotere) in the treatment of cancer Seminars in Oncology 27(2 Suppl 3: 1-2
Skarlos, D.V.; Bai, M.; Goussia, A.; Samantas, E.; Galani, E.; Tsavdaridis, D.; Karina, M.; Papakostas, P.; Konstantara, A.; Fountzilas, G. 2007: Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group Anticancer Research 27(4c): 2973-2983